The Roots of MALT: How Inflammation Drives the Disease
At a Glance
MALT lymphoma is primarily caused by chronic inflammation resulting from persistent infections, like H. pylori in the stomach, or autoimmune diseases. Treating this underlying trigger can often stop or cure the lymphoma entirely.
The development of MALT lymphoma (extranodal marginal zone lymphoma) is a fascinating example of how the body’s own defense system can sometimes go off course. Unlike most cancers that seem to appear out of nowhere, MALT lymphoma is usually the result of your immune system working “overtime” to fight off a long-term threat.
The Link Between Inflammation and Cancer
Normally, when your body faces an infection or an autoimmune attack, it sends B-cells (a type of white blood cell) to the area to protect you. These cells gather in the mucosa—the moist linings of your organs.
If the irritation never goes away—a state called chronic inflammation—these B-cells are constantly told to divide and stay active. Over time, this constant activity can lead to genetic “errors.” One of the most common errors is the activation of the NF-κB pathway, a signaling system that tells cells to keep growing and refuse to die [1]. Eventually, these cells become “autonomous,” meaning they no longer need the original infection to keep growing as a cancer.
Gastric MALT: The H. Pylori Connection
The stomach is the most common site for this disease. In the vast majority of gastric MALT cases, the culprit is a bacterium called Helicobacter pylori (H. pylori) [2][3].
- The Cause: The bacteria cause a persistent infection in the stomach lining.
- The Result: The immune system builds up lymphoid tissue (which isn’t normally in the stomach) to fight the bacteria.
- The Treatment: Because the cancer is “driven” by the bacteria, taking a targeted course of antibiotics to kill the H. pylori can cause the lymphoma to disappear entirely in many patients [2][4]. Be aware that the antibiotics may temporarily cause stomach upset, but this approach offers a high chance of curing the lymphoma without traditional chemotherapy.
Non-Gastric MALT: Other Triggers
MALT lymphoma can happen anywhere there is mucosa, and each location often has its own specific “trigger.” These can be other types of bacteria or autoimmune diseases, where the immune system mistakenly attacks the body’s own healthy tissue [5].
| Location | Common Triggers / Associated Conditions |
|---|---|
| Salivary Glands | Sjögren’s syndrome (an autoimmune disease causing dry eyes and mouth) [5][6]. |
| Thyroid | Hashimoto’s thyroiditis (an autoimmune disease where the body attacks the thyroid) [5]. |
| Eyes (Ocular Adnexa) | Often linked to Chlamydia psittaci (a bacteria sometimes carried by birds), though this varies by region [5]. |
| Skin (Cutaneous) | Can be associated with Borrelia burgdorferi (the bacteria that causes Lyme disease) [5]. |
| Small Intestine | Associated with Campylobacter jejuni [5]. |
| Lungs | May be linked to the bacteria Achromobacter xylosoxidans or autoimmune conditions [5]. |
Why the “Extranodal” Label Matters
You will often hear this called extranodal marginal zone lymphoma [7]. The word extranodal simply means “outside of the lymph nodes.” This is a key feature of MALT lymphoma. Because it starts in organs like the stomach or lungs rather than the central lymphatic system, it often stays localized (stays in one spot) for a very long time [8]. This makes it much easier to monitor and treat than lymphomas that are spread throughout the body’s lymph node network.
However, if specific genetic changes occur—like the t(11;18) translocation—the cancer may become less dependent on the original trigger and may require more direct cancer treatments like radiation or medication [9].
Common questions in this guide
What causes MALT lymphoma?
Can antibiotics cure MALT lymphoma?
What does extranodal marginal zone lymphoma mean?
How do autoimmune diseases trigger MALT lymphoma?
What does a t(11;18) translocation mean for my treatment?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on the location of my lymphoma, which specific infection or autoimmune condition should I be tested for?
- 2.If we treat the underlying infection (like H. pylori or Chlamydia), how long does it usually take to see if the lymphoma is responding?
- 3.How does having an autoimmune disease like Sjögren's or Hashimoto's change my long-term monitoring plan?
- 4.Does the presence of a genetic translocation like t(11;18) mean that my lymphoma has become 'autonomous' or independent of the original inflammation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Molecular Mechanisms and Treatment Strategies for Helicobacter pylori-Induced Gastric Carcinogenesis and Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Myrou A
Cureus 2024; (16(5)):e60326 doi:10.7759/cureus.60326.
PMID: 38883131 - 2
Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
Nakamura S, Hojo M
Journal of clinical medicine 2022; (12(1)) doi:10.3390/jcm12010120.
PMID: 36614921 - 3
[Characteristics of Gastric Mucosa-associated Lymphoid Tissue Lymphoma in Korea].
Kim TW, Kim JS
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2024; (84(6)):243-250 doi:10.4166/kjg.2024.108.
PMID: 39716946 - 4
Helicobacter pylori and Gastric Cancer.
Kim J, Wang TC
Gastrointestinal endoscopy clinics of North America 2021; (31(3)):451-465 doi:10.1016/j.giec.2021.03.003.
PMID: 34053633 - 5
Non-gastric mucosa-associated lymphoid tissue lymphomas: a narrative review of pathogenesis, diagnosis, and treatment strategies.
Mallick H, Karri V, Dalia S
Annals of translational medicine 2025; (13(6)):78 doi:10.21037/atm-25-114.
PMID: 41502427 - 6
Composite Epstein-Barr virus-positive mucosa-associated lymphoid tissue lymphoma and Epstein-Barr virus-negative diffuse large B-cell lymphoma in the parotid salivary gland of a patient with Sjögren's syndrome and rheumatoid arthritis: a case report.
Gorodetskiy VR, Probatova NA, Konovalov DM, et al.
Journal of medical case reports 2020; (14(1)):12 doi:10.1186/s13256-019-2331-1.
PMID: 31948469 - 7
Update on B-cell lymphoproliferative disorders of the gastrointestinal tract.
Plummer RM, Linden MA, Beckman AK
Seminars in diagnostic pathology 2021; (38(4)):14-20 doi:10.1053/j.semdp.2021.03.006.
PMID: 33863577 - 8
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Salar A, Domingo-Domenech E, Panizo C, et al.
Blood 2017; (130(15)):1772-1774 doi:10.1182/blood-2017-07-795302.
PMID: 28801448 - 9
Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results.
Toyoda K, Maeshima AM, Nomoto J, et al.
Annals of hematology 2019; (98(7)):1675-1687 doi:10.1007/s00277-019-03671-5.
PMID: 30923996
This page provides educational information about the causes and triggers of MALT lymphoma. It does not replace professional medical advice, and you should always consult your oncologist about your specific diagnosis and treatment plan.
Get notified when new evidence is published on MALT lymphoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.